I agree that this site is using cookies. You can find further informations here.
X
Gladiator, André
23  results:
Search for persons X
?
1

Correction: Transitioning subcutaneous immunoglobulin 20% t..:

Keith, Paul K. ; Cowan, Juthaporn ; Kanani, Amin...
Allergy, Asthma & Clinical Immunology.  19 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
2

Development of a primary care screening algorithm for the e..:

Messelink, Marianne A. ; Berbers, Roos M. ; van Montfrans, Joris M....
Allergy, Asthma & Clinical Immunology.  19 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
3

Real-World Use, Safety, and Patient Experience of 20% Subcu..:

Fasshauer, Maria ; Borte, Michael ; Bitzenhofer, Michaela...
Advances in Therapy.  40 (2023)  12 - p. 5168-5187 , 2023
Link: https://doi.org/10.1007/..
 
?
4

Real-World Use, Safety, and Patient Experience of 20% Subcu..:

Fasshauer, Maria ; Borte, Michael ; Bitzenhofer, Michaela...
https://boris.unibe.ch/186629/.  , 2023
Link: https://boris.unibe.ch/1..
 
?
5

Development of a primary care screening algorithm for the e..:

Messelink, Marianne A ; Berbers, Roos M ; van Montfrans, Joris M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224324/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
6

Real-World Use, Safety, and Patient Experience of 20% Subcu..:

Adis journalson behalf of ; Maria Fasshauer ; Michael Borte...
doi:10.6084/m9.figshare.23932341.v2.  , 2023
Link: https://doi.org/10.6084/..
 
?
7

Correction: Transitioning subcutaneous immunoglobulin 20% t..:

Keith, Paul K ; Cowan, Juthaporn ; Kanani, Amin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290310/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
8

Correction: Transitioning subcutaneous immunoglobulin 20% t..:

Paul K. Keith ; Juthaporn Cowan ; Amin Kanani...
https://doi.org/10.1186/s13223-023-00805-3.  , 2023
Link: https://doi.org/10.1186/..
 
?
9

Development of a primary care screening algorithm for the e..:

Marianne A. Messelink ; Roos M. Berbers ; Joris M. van Montfrans...
https://doi.org/10.1186/s13223-023-00790-7.  , 2023
Link: https://doi.org/10.1186/..
 
?
10

Real-World Use, Safety, and Patient Experience of 20% Subcu..:

Fasshauer, Maria ; Borte, Michael ; Bitzenhofer, Michaela...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611600/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
11

Transitioning subcutaneous immunoglobulin 20% therapies in ..:

Keith, Paul K. ; Cowan, Juthaporn ; Kanani, Amin...
Allergy, Asthma & Clinical Immunology.  18 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
12

Real-world utilization, safety and patient experience of 20..:

Fasshauer, Maria ; Borte, Michael ; Bitzenhofer, Michaela...
https://boris.unibe.ch/175541/.  , 2022
Link: https://boris.unibe.ch/1..
 
?
13

Transitioning subcutaneous immunoglobulin 20% therapies in ..:

Paul K. Keith ; Juthaporn Cowan ; Amin Kanani...
https://doi.org/10.1186/s13223-022-00709-8.  , 2022
Link: https://doi.org/10.1186/..
 
?
14

Transitioning subcutaneous immunoglobulin 20% therapies in ..:

Keith, Paul K ; Cowan, Juthaporn ; Kanani, Amin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358831/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
15

Infusion parameters of 20% subcutaneous immunoglobulin for ..:

Meckley, Lisa M. ; Wu, Yanyu ; Tzivelekis, Spiros..
Annals of Allergy, Asthma & Immunology.  127 (2021)  5 - p. 568-574.e1 , 2021
Link: https://doi.org/10.1016/..
 
1-15